Elanco三季度营收12.65亿美元增11%：净利润1,800万美元、每股收益0.04美元，调整后净利润1.36亿美元、调整后每股收益0.27美元
印第安纳州印第安纳波利斯的动物保健公司 Elanco Animal Health（纽约证券交易所代码 ELAN）11月6日发布截至2026年9月30日的第三季度业绩：当季营收12.65亿美元，同比增长11%，按固定汇率有机增长为9%；报告净利润1,800万美元，去年同期为净亏损3,400万美元；调整后净利润1.36亿美元；调整后 EBITDA 为2.43亿美元，业绩稿列示的调整后 EBITDA 利润率为19.5%。每股收益方面，报告摊薄每股收益0.04美元，去年同期为每股亏损0.07美元；调整后每股收益0.27美元。季末公司净杠杆率为调整后 EBITDA 的2.9倍。
指引安排方面，公司在同一份业绩稿中上调2026全年指引并给出2026年第四季度指引与2027全年的初步展望：全年营收指引上调至51.55亿至51.80亿美元，调整后 EBITDA 指引上调至10.50亿至10.65亿美元，调整后每股收益指引上调至1.17至1.20美元，创新营收目标上调至12.75亿美元；业绩稿注明，全年与四季度财务指引反映的是10月底的汇率水平。公司于11月6日美东时间上午8时举行网络直播与电话会，由管理层说明三季度财务与运营结果、四季度与全年指引及2027年初步展望。
本稿数字全部取自公司业绩稿正文与其列示的汇总表；调整后口径为公司非通用会计准则口径，与报告口径并列时以业绩稿原文为准。
（来源：Elanco Animal Health）
Elanco Third-Quarter Revenue Rises 11% to $1.265 Billion: Net Income of $18 Million and EPS of $0.04, With Adjusted Net Income of $136 Million and Adjusted EPS of $0.27
Elanco Animal Health Incorporated (NYSE: ELAN), based in Indianapolis, Indiana, on November 6 reported financial results for the third quarter of 2026. Revenue was $1.265 billion, an increase of 11% year over year, with 9% organic constant-currency growth. Reported net income was $18 million, compared with a net loss of $34 million in the same period of 2025; adjusted net income was $136 million; and adjusted EBITDA was $243 million, with an adjusted EBITDA margin of 19.5% as presented in the release. Reported diluted EPS was $0.04, compared with a loss of $0.07 per diluted share a year earlier, and adjusted EPS was $0.27. The net leverage ratio stood at 2.9 times adjusted EBITDA.
Alongside the results, the company raised its full-year 2026 guidance, provided guidance for the fourth quarter of 2026, and gave an early outlook for the full year 2027: full-year revenue guidance was raised to $5.155 billion to $5.18 billion, adjusted EBITDA guidance to $1.05 billion to $1.065 billion, adjusted EPS guidance to $1.17 to $1.20, and the innovation revenue target to $1.275 billion; the release notes that the full-year and fourth-quarter guidance reflects foreign exchange rates as of the end of October. Elanco hosted a webcast and conference call at 8:00 a.m. Eastern Time on November 6, at which executives reviewed the quarter's results, the fourth-quarter and full-year guidance and the early 2027 outlook.
All figures in this report are taken from the body of the company's earnings release and its summary tables; adjusted figures are the company's non-GAAP measures as presented alongside the reported figures.
(Source: Elanco Animal Health)
来源：Elanco Animal Health
发布：GSM·美国（发布链接）
图片来源：图：Elanco 公司标志。公共领域，经 Wikimedia Commons。 / Photo: The Elanco company logo. Public domain, via Wikimedia Commons.
GSM Global · 本篇英文版 English edition of this story
